Entrada Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $14k | 2.4k | 5.80 |
| 2025-06-30 | $16k | 2.4k | 6.72 |
| 2025-03-31 | $22k | 2.4k | 9.04 |
| 2024-12-31 | $42k | 2.4k | 17.29 |
| 2024-09-30 | $39k | 2.4k | 15.98 |
| 2024-06-30 | $25k | 1.8k | 14.25 |
| 2024-03-31 | $25k | 1.8k | 14.17 |
| 2023-12-31 | $27k | 1.8k | 15.09 |
| 2023-09-30 | $28k | 1.8k | 15.80 |
| 2023-06-30 | $27k | 1.8k | 15.14 |
| 2022-03-31 | $7.0k | 708 | 9.89 |
| 2021-12-31 | $12k | 708 | 16.95 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors